Liver support for fulminant hepatic failure: Is it time to use the Molecular Adsorbents Recycling System in children?

Pediatric Critical Care Medicine

Volumn 6, Issue 5, 2005, Pages 585-591

  Tissières, Pierre ^a   Sasbón, Jorge S ^b   Devictor, Denis ^a  

^a BICÊTRE HOSPITAL   (France)

^b HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Child; Dialysis; Fulminant hepatic failure; Liver assist device; Liver support; Molecular Adsorbents Recycling System

Indexed keywords

ADSORBENT; ALBUMIN;

ALBUMIN DIALYSIS SYSTEM; CHRONIC LIVER DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DIALYSIS; DISEASE SEVERITY; EXTRACORPOREAL CIRCULATION; GRAFT DYSFUNCTION; HEALTH CARE COST; HEPATORENAL SYNDROME; HUMAN; LIVER ASSIST DEVICE; LIVER CIRRHOSIS; LIVER FAILURE; MEDLINE; MORALITY; OUTCOMES RESEARCH; PEDIATRICS; PRIORITY JOURNAL; PROGNOSIS; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RECYCLING; REVIEW; TREATMENT INDICATION;

EID: 24944475764     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000170624.29667.7B     Document Type: Review

References (77)

1. Devictor D, Desplanques L, Debray D, et al: Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology 1992; 16:1156-1162
2. Durand P, Debray D, Mandel R, et al: Acute liver failure in infancy: A 14-year experience of a pediatric liver transplantation center. J Pediatr 2001; 139:871-876
3. Balistreri WF: Transplantation for childhood liver disease: An overview. Liver Transpl Surg 1998; 4:818-523
4. Mondragon R, Mieli-Vergani G, Heaton ND, et al: Liver transplantation for fulminant liver failure in children. Transpl Int 1992; 5(Suppl 1):S206-S208
5. Tan KC, Mondragon RS, Vougas V, et al: Liver transplantation for fulminant hepatic failure and late-onset hepatic failure in children. Br J Surg 1992; 79:1192-1194
6. Alper G, Jarjour IT, Reyes JD, et al: Outcome of children with cerebral edema caused by fulminant hepatic failure. Pediatr Neurol 1998; 18:299-304
7. Ee LC, Shepherd RW, Cleghorn GJ, et al: Acute liver failure in children: A regional experience. J Paediatr Child Health 2003; 39:107-110
8. Tissieres P, Prontera W, Chevret L, et al: The pediatric risk of mortality score in infants and children with fulminant liver failure. Pediatr Transplant 2003; 7:64-68
9. Lidofsky SD: Liver transplantation for fulminant hepatic failure. Gastroenterol Clin North Am 1993; 22:257-269
10. McCashland TM, Shaw BW Jr, Tape E: The American experience with transplantation for acute liver failure. Semin Liver Dis 1996; 16:427-433
11. Uribe M, Buckel E, Ferrario M, et al: Epidemiology and results of liver transplantation for acute liver failure in Chile. Transplant Proc 2003; 35:2511-2512
12. Chen HL, Chang CJ, Kong MS, et al: Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology 2004; 39:58-63
13. Millar AJ, Spearman W, McCulloch M, et al: Liver transplantation for children: The Red Cross Children's Hospital experience. Pediatr Transplant 2004; 8:136-144
14. Fonseca JC, Souza RA, Brasil LM, et al: Fulminant hepatic failure in children and adolescents in Northern Brazil. Rev Soc Bras Med Trop 2004; 37:67-69
15. Aydogdu S, Ozgenc F, Yurtsever S, et al: Our experience with fulminant hepatic failure in Turkish children: Etiology and outcome. J Trop Pediatr 2003; 49:367-370
16. Redeker A, Yamahori H: Controlled trial of exchange-transfusion therapy in fulminant hepatitis. Lancet 1973; 301:3-6
17. O'Grady JG, Gimson AE, O'Brien CJ, et al: Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94:1186-1192
18. Kjaergard LL, Liu J, Als-Nielsen B, et al: Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: A systematic review. JAMA 2003; 289:217-222
19. Liu JP, Gluud LL, Als-Nielsen B, et al: Artificial and bioartificial support systems for liver failure. Cochrane Database Syst Rev 2004; 1:CD003628
20. Horslen SP, Hammel JM, Fristoe LW, et al: Extracorporeal liver perfusion using human and pig livers for acute liver failure. Transplantation 2000; 70:1472-1478
21. Pascher A, Sauer IM, Hammer C, et al: Extracorporeal liver perfusion as hepatic assist in acute liver failure: A review of world experience. Xenotransplantation 2002; 9:309-324
22. Millis JM, Cronin DC, Johnson R, et al: Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: System modifications and clinical impact. Transplantation 2002; 74:1735-1746
23. van de Kerkhove MP, Di Florio E, Scuderi V, et al: Phase I clinical trial with the AMC-bioartificial liver. Int J Artif Organs 2002; 25:950-959
24. Ellis AJ, Hughes RD, Wendon JA, et al: Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996; 24:1446-1451
25. Patzer JF II, Mazariegos GV, Lopez R, et al: Novel bioartificial liver support system: Preclinical evaluation. Ann N Y Acad Sci 1999; 875:340-352
26. Sussman NL, Gislason GT, Conlin CA, et al: The Hepatix extracorporeal liver assist device: Initial clinical experience. Artif Organs 1994; 18:390-396
27. Rozga J, Podesta L, LePage E, et al: A bioartificial liver to treat severe acute liver failure. Ann Surg 1994; 219:538-544
28. Mazariegos GV, Patzer JF II, Lopez RC, et al: First clinical use of a novel bioartificial liver support system (BLSS). Am J Transplant 2002; 2:260-266
29. Demetriou AA, Brown RS Jr, Busuttil RW, et al: Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004; 239:660-667
30. Gerlach JC, Zeilinger K, Sauer IM, et al: Extracorporeal liver support: porcine or human cell based systems? Int J Artif Organs 2002; 25:1013-1018
31. Wilkinson AH, Ash SR, Nissenson AR: Hemodiabsorption in treatment of hepatic failure. J Transpl Coord 1998; 8:43-50
32. Hughes RD, Pucknell A, Routley D, et al: Evaluation of the BioLogic-DT sorbent-suspension dialyser in patients with fulminant hepatic failure. Int J Artif Organs 1994; 17:657-662
33. Mazariegos G, Ash S, Patzer J: Preliminary results: randomized clinical trial of the BioLogic-DT in treatment of acute hepatic failure (AHF) with coma. Abstr. Artif Organs 1997; 21:529
34. He JQ, Chen CY, Deng JT, et al: Clinical study on the treatment of fatal hepatitis with artificial liver support system. Chin Crit Care Med 2000; 12:105-108
35. Ash SR: Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy. Adv Ren Replace Ther 2002; 9:3-18
36. Toshiba M, Inoue K, Sekiyama K, et al: Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs 1996; 20:1169-1172
37. Okamoto K, Kurose M, Ikuta Y, et al: Prolonged artificial liver support in a child with fulminant hepatic failure. Asaio J 1996; 42:233-235
38. Kubota T, Sekido H, Takeda K, et al: Acute hepatic failure with deep hepatic coma treated successfully by high-flow continuous hemodiafiltration and living-donor liver transplantation: A case report. Transplant Proc 2003; 35:394-396
39. Sadamori H, Yagi T, Inagaki M, et al: High-flow-rate haemodiafiltration as a brain-support therapy proceeding to liver transplantation for hyperacute fulminant hepatic failure. Eur J Gastroenterol Hepatol 2002; 14:435-439
40. Mitzner SR, Klammt S, Peszynski P, et al: Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system. Ther Apher 2001; 5:417-422
41. Awad SS, Rich PB, Kolla S, et al: Characteristics of an albumin dialysate hemodiafiltration system for the clearance of unconjugated bilirubin. Asaio J 1997; 43:M745-M749
42. Awad SS, Sawada S, Soldes OS, et al: Can the clearance of tumor necrosis factor alpha and interleukin 6 be enhanced using an albumin dialysate hemodiafiltration system? Asaio J 1999; 45:47-49
43. Awad SS, Swaniker F, Magee J, et al: Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. Surgery 2001; 130:354-362
44. Stange J, Ramlow W, Mitzner S, et al: Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins. Artif Organs 1993; 17:809-813
45. Loock J, Mitzner SR, Peters E, et al: Amino acid dysbalance in liver failure is favourably influenced by recirculating albumin dialysis (MARS). Liver 2002; 22(Suppl 2):35-39
46. Klammt S, Stange J, Mitzner SR, et al: Extracorporeal liver support by recirculating albumin dialysis: Analysing the effect of the first clinically used generation of the MAR-System. Liver 2002; 22(Suppl 2):30-34
47. Mitzner SR, Stange J, Klammt S, et al: Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephrol 2001; 12(Suppl 17):S75-S82
48. Mullhaupt B, Kullak-Ublick GA, Ambuhl P, et al: First clinical experience with Molecular Adsorbent Recirculating System (MARS) in six patients with severe acute on chronic liver failure. Liver 2002; 22(Suppl 2):59-62
49. Schmidt LE, Wang LP, Hansen BA, et al: Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trial. Liver Transpl 2003; 9:290-297
50. Novelli G, Rossi M, Pretagostini R, et al: MARS (Molecular Adsorbent Recirculating System): Experience in 34 cases of acute liver failure. Liver 2002; 22(Suppl 2):43-47
51. Steiner C, Mitzner S: Experiences with MARS liver support therapy in liver failure: Analysis of 176 patients of the International MARS Registry. Liver 2002; 22(Suppl 2):20-25
52. Heemann U, Treichel U, Loock J, et al: Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study. Hepatology 2002; 36:949-958
53. Stange J, Mitzner SR, Klammt S, et al: Liver support by extracorporeal blood purification: A clinical observation. Liver Transpl 2000; 6:603-613
54. Novelli G, Rossi M, Pretagostini R, et al: A 3-year experience with Molecular Adsorbent Recirculating System (MARS): Our results on 63 patients with hepatic failure and color Doppler US evaluation of cerebral perfusion. Liver Int 2003; 23(Suppl 3):10-15
55. Ben Abraham R, Szold O, Merhav H, et al: Rapid resolution of brain edema and improved cerebral perfusion pressure following the molecular adsorbent recycling system in acute liver failure patients. Transplant Proc 2001; 33:2897-2899
56. Lamesch P, Jost U, Schreiter D, et al: Molecular adsorbant recirculating system in patients with liver failure. Transplant Proc 2001; 33:3480-3482
57. Manz T, Ochs A, Bisse E, et al: Liver support: A task for nephrologists? Extracorporeal treatment of a patient with fulminant Wilson crisis. Blood Purif 2003; 21:232-236
58. Sen S, Felldin M, Steiner C, et al: Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson's disease. Liver Transpl 2002; 8:962-967
59. Kreymann B, Seige M, Schweigart U, et al: Albumin dialysis: Effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation. A new possibility for the elimination of protein-bound toxins. J Hepatol 1999; 31:1080-1085
60. McIntyre CW, Fluck RJ, Freeman JG, et al: Characterization of treatment dose delivered by albumin dialysis in the treatment of acute renal failure associated with severe hepatic dysfunction. Clin Nephrol 2002; 58:376-383
61. Prokurat S, Grenda R, Lipowski D, et al: MARS procedure as a bridge to combined liver-kidney transplantation in severe chromium-copper acute intoxication: A paediatric case report. Liver 2002; 22(Suppl 2):76-77
62. Zhou XM, Miao JY, Yang Y, et al: Clinical experience with molecular adsorbent recirculating system (MARS) in patients with drug-induced liver failure. Artif Organs 2004; 28:483-486
63. Shi Y, He J, Chen S, et al: MARS: Optimistic therapy method in fulminant hepatic failure secondary to cytotoxic mushroom poisoning. A case report. Liver 2002; 22(Suppl 2):78-80
64. Faybik P, Hetz H, Baker A, et al: Extracorporeal albumin dialysis in patients with Amanita phalloides poisoning. Liver Int 2003; 23(Suppl 3):28-33
65. Marasachio M, Swanicker J, Bartlett R, et al: Use of extracorporeal hepatic support for fulminant hepatic failure: Preliminary experience in pediatric patients. Abstr. Pediatr Transplant 2003; 7:125
66. Hommann M, Kasakow LB, Geoghegan J, et al: Application of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15-month-old child. Pediatr Transplant 2002; 6:340-343
67. Ambrosino G, Naso A, Zancan L, et al: Molecular absorbent recirculating system: Cytochines modifications during treatment in pediatric case. Abstr. Pediatr Transplant 2003; 7:81
68. Covic A, Goldsmith DJ, Gusbeth-Tatomir P, et al: Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion. Liver Int 2003; 23(Suppl 3):21-27
69. Migdal M, Rubik J, Prokurat S, et al: Usefulness of molecular absorbent recirculating system (MARS) in pediatric intensive care. Abstr. Pediatr Crit Care Med 2003; 4:A187
70. Kellersmann R, Gassel HJ, Buhler C, et al: Application of Molecular Adsorbent Recirculating System in patients with severe liver failure after hepatic resection or transplantation: Initial single-centre experiences. Liver 2002; 22(Suppl 2):56-58
71. Liu YH, Wang Y, Yu LX, et al: Artificial liver support molecular adsorbents recirculating system therapy as a bridge to re-transplantation in two cases of long anhepatic duration. Hepatobiliary Pancreat Dis Int 2004; 3:316-317
72. Tissieres P, Debray D, Dousset B, et al: Are London and Clichy indicators of prognosis accurate in infants and children with fulminant liver failure. Abstr. Pediatr Transplant 1998; 2:89
73. Centeno MA, Bes DF, Sasbon JS: Mortality risk factors of a pediatric population with fulminant hepatic failure undergoing orthotopic liver transplantation in a pediatric intensive care unit. Pediatr Crit Care Med 2002; 3:227-233
74. Carroll CL, Goodman DM, Superina RA, et al: Timed Pediatric Risk of Mortality Scores predict outcomes in pediatric liver transplant recipients. Pediatr Transplant 2003; 7:289-295
75. Sauer IM, Goetz M, Steffen I, et al: In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatology 2004; 39:1408-1414
76. Lee WM: Acetaminophen and the US Acute Liver Failure Study Group: Lowering the risks of hepatic failure. Hepatology 2004; 40:6-9
77. Devictor D. Fulminant hepatitis A: Liver transplantation or vaccination? Pediatr Crit Care Med 2002; 3:315-316